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Abstract 
 
Routine cervical cancer screening has significantly decreased the mortality rate of cervical 
cancer. Today, cervical cancer predominantly affects those who are rarely or never screened. 
Government programs are in place to provide cervical cancer screening at little to no cost, yet 
screening rates remain suboptimal. This project evaluated an evidence-based intervention to 
increase cervical cancer screening among underserved women in a federally qualified health 
center (FQHC). Female patients ages 21 to 65 years without history of hysterectomy (n=1,710) 
were sent reminders to their phones through the electronic health record (EHR). The message 
included educational material about the screening process and an announcement regarding 
government aid for free or reduced cost screening. The number of patients who made an 
appointment after receiving the message was assessed two months later. In total, 156 responses 
were collected, and 28 patients made an appointment for screening. The most frequently 
observed category of Ethnicity was Hispanic/Latina (n = 24, 86%). The most frequently 
observed category of Insurance was Title X (n = 13, 46%). The observations for Age had an 
average of 41.04 (SD = 9.93). Using an EHR communication function to send motivational 
reminders has shown some promise for increasing cervical cancer screening, thereby reducing 
cervical cancer mortality among the underserved. 
Keywords: Cervical cancer screening, Papanicolaou Test, Federally Qualified Health 
Clinic, underserved women 
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Increasing Cervical Cancer Screening in a Federally Qualified Health Center 
 Most women with cervical cancer are asymptomatic until the disease is clinically 
apparent (Canavan & Doshi, 2000). Routine screenings help detect early abnormal cytologic 
changes and can prevent their progression from preinvasive to invasive (Canavan & Doshi, 
2000). Although routine screening has decreased the mortality rate of cervical cancer, many 
women do not get screened often enough, if at all. To further decrease the mortality rate, women 
must be screened according to clinical practice guidelines.  
Problem Statement 
Cervical cancer is the third most common gynecologic cancer diagnosis and cause of 
death among gynecologic cancers for women in the United States (Boardman, 2019; Centers for 
Disease Control and Prevention [CDC], 2018a; Frumovitz, 2020). From 2011 to 2015, cervical 
cancer deaths increased 2.3% annually (Weir, Thompson, Soman, Miller, & Leadbetter, 2015). 
An estimated 570,000 new cases of cervical cancer were diagnosed in 2018, representing 6.6% 
of all female cancers (World Health Organization [WHO], 2019). The American Cancer Society 
(ACS) (2020b) estimates that in 2020 13,800 cases of invasive cervical cancer will be diagnosed 
and approximately 4,290 women will die from cervical cancer in the United States. Incidence for 
cervical cancer is more prevalent among Hispanic and African American women, and the 
underinsured are most likely to develop cervical cancer (ACS, 2020b; Boardman, 2019; 
Frumovitz, 2020). The Papanicolaou (Pap) smear detects cytological abnormalities 
microscopically and can reduce the incidence of cervical cancer by up to 80% (ACS, 2020b; 
Arbyn et al., 2010).  
The United States Preventive Service Task Force (USPSTF) (2018) recommends cervical 
cytology every three years for women aged 21 to 29 years of age. For women aged 30 to 65 
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years, the recommendation is to screen every three years with cytology alone, every five years 
with HPV alone, or every five years with cytology and HPV cotesting (USPSTF, 2018). 
Healthy People 2020 has set a goal of reducing cervical/uterine cancer to 2.2 deaths per 
100,000 women compared to a goal of 2.4 deaths per 100,000 women in 2007 (Office of Disease 
Prevention and Health Promotion [ODPHP], 2020). It is estimated that the lower death rate could 
be achieved through attaining a 93% screening level and applying the USPSTF guidelines (Hall 
et al., 2018; ODPHP, 2020). According to the CDC (2017), 69% of women 18 years of age and 
over received the Pap test within the past three years. Over 50% of new cervical cancer cases are 
estimated to occur in women who are rarely or were never screened (Crawford, Benard, King, & 
Thomas, 2016). 
Despite the effectiveness of routine screening in the early detection of treatable dysplasia 
and reduced mortality from cervical cancer, many women are either not screening often enough 
or at all (Levano et al., 2014). To reach the Healthy People 2020 cancer reduction goal, women 
must be screened according to clinical practice guideline. 
A Federally Qualified Health Center (FQHC) in Phoenix, Arizona provides 
comprehensive care to predominantly uninsured individuals of all ages. The FQHC offers 
primary care, prenatal care, acute and chronic illness management, and preventive care. 
Although the clinic makes every effort possible to deliver comprehensive care to all patients 
regardless of financial situation, it has struggled to meet its goal for Title X-funded cervical 
cancer screenings. The clinic goal is a screening rate of 65%, but they have fallen short with a 
rate of 54%. This may lead to undetected cancers and a preventable increase in mortality. The 
low screening rate could also impact funding by Title X, leading to a loss of benefit for patients. 
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Purpose and Rationale 
The purpose of this project was to identify and implement a tested intervention that has been 
demonstrated to increase cervical cancer screening rates in low income, medically underserved women. 
The overall goal is early identification and treatment of cervical dysplasia that, left undetected and 
untreated, could progress to cervical cancer.  
Literature Review 
 Many women are resistant to receive cervical cancer screening despite the its 
effectiveness in reducing risk of mortality. Reduced awareness of cancer and preventive 
screening tests, fear of out-of-pocket costs, anxiety regarding the procedure, and lack of time for 
women to make an appointment are common barriers to routine screening. 
Awareness 
 Minority women are often unaware of cervical cancer and screening practices (Nardi, 
Sandhu, & Selix, 2016). Strohl et al. (2015) found that 74% of women knew that the Pap test 
screened for cervical cancer, but only 35% of them could accurately recognize the risk factors.  
Providers acknowledge that there is a lack of comprehension about what testing is being done 
during the pelvic exam, with some women believing the Pap is testing for sexually transmitted 
infections (STIs). Some also believe that the Pap test is completed with every pelvic exam (Nardi 
et al., 2016). Women were unaware of the recommended frequency for screening while some 
believed that screening was ineffective (Baezconde-Garbanati, Murphy, Moran, & Cortessis, 
2013; Flores & Acton, 2013). Inadequate knowledge of the cervical cancer screening process and 
possible treatment options leaves women reluctant or fearful of routine testing. Nardi et al. 
(2016) found that many women believe that an abnormal Pap test inevitably results in a 
hysterectomy, or worse, death.  
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 The CDC developed the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) to improve screening among medically underserved populations (Levano et al., 
2014). The NBCCEDP works to provide low-cost cervical cancer screening to low-income, 
uninsured, and underinsured women (Levano et al., 2014). Although the NBCCEDP has 
provided more than 10 million Pap tests and diagnosed thousands of cervical cancers and 
precancerous cervical lesions, many women remain unaware of this benefit and consequently 
decline or miss opportunities for screening (Levano et al., 2014). 
Insurance 
 A data source for appraising Healthy People targets in cancer is The National Health 
Interview Survey (NHIS) (Brown et al., 2014). NHIS highlights a convincing association 
between health insurance and cancer screening completion. Zhao, Okoro, Li, and Town (2017) 
used the Behavioral Risk Factor Surveillance System collected data on healthcare access and 
cancer screenings. Participants’ health insurance status was categorized as adequately insured, 
underinsured, or never insured. Compared to adequately insured adults, underinsured and never 
insured adults were 19% less likely to receive cervical cancer screening (Zhao et al., 2017). 
Health disparities persist despite attempts to increase health insurance coverage across the nation 
(Brown et al., 2014; Zhao et al., 2017).   
 Among insured women, 78.2% had a Pap test within the past three years; however, only 
57.3% of uninsured women had a Pap test (CDC, 2017). The rates of both insured and uninsured 
women receiving Pap tests fall short of the Healthy People 2020 goal, but it is particularly low 
among the under- and uninsured. In a survey of 524 women residing in 17 counties in Texas, 
61.6% of the participants claimed that out-of-pocket costs was an impediment to screening 
(Akinlotan et al., 2017). Likewise, in another survey of 43 participants in Britain, out-of-pocket 
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costs were also a barrier to obtaining the Pap test (Marlow, Waller, & Wardle, 2015). In their 
study, Studts and colleagues identified the circumstances that could discourage women from 
completing routine cervical cancer screening (Studts, Tarasenko, & Shoenberg, 2013).Of the 543 
participants (67%) stated that they would be more likely to complete screening if it were covered 
by their insurance (Studts et al., 2013).   
Anxiety 
 In a survey of 524 women receiving grant-funded cervical cancer screening in Texas, 
38.7% reported feeling anxious about the Pap test (Akinlotan et al., 2017). In the same survey, 
53.1% of participants were nervous regarding the possibility of finding cancer, 25.6% reported 
feeling embarrassed by having the procedure done, and 23.6% anticipated a painful experience, 
and therefore did not follow through with screening (Akinlotan et al., 2017). Marlow et al. 
(2015) found that participants reported similar negative emotions regarding the screening as 
reasons why they have rarely or never had a Pap test.  
 In the Netherlands, 789 female participants 30 to 60 years of age measured health-related 
quality of life (HRQoL) using the EuroQol (European quality of life) classification (EQ-5D) and 
the 12-item Short-Form Health Survey (SF-12) (Korfage et al., 2012). More than 20% of 
participants reported feeling shame and apprehension during the procedure and 25% of 
participants viewed screening as burdensome (Korfage et al., 2012).  
 Studts et al. (2013) found that 78% of participants reported that fear of cancer being 
found made them reluctant to test at all. Additionally, 64% were hesitant to have the Pap test 
because their provider was male, and 56% felt embarrassed to have the test (Studts et al., 2013).  
 In an exploration of psychosocial barriers to cervical cancer screening of women in 
Mexico, researchers found that 36.9% of women reported being too embarrassed to receive 
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testing, 31.4% reported the Pap test makes them worry, and 24.1% were afraid the test would be 
too painful (Marvan, Ehrenzweig, & Catillo-Lopez, 2013).  
Time Limitation 
 Crawford et al. (2016) examined of nonfinancial barriers to civilian women in the United 
States meeting cervical cancer screening recommendations using the Behavioral Risk Factor 
Surveillance System (BRFSS). Higher percentages of never-before or rarely screened women 
reported multiple comorbidities such as depression, diabetes, and heart disease and cited them as 
a reason for not having the Pap test completed (Crawford et al., 2016). These women received 
routine care for their comorbidities but did not schedule extra appointments for cervical cancer 
screening (Crawford et al., 2016). 
 Women in the metropolitan Chicago area were enrolled in a qualitative study and 
interviewed with questions guided by the Theory of Reasoned Action to elucidate personal 
viewpoints that influence cancer screening decision-making (Nonzee et al., 2015). Participants 
mentioned work conflicts and accompanying loss of wages as a causative factor to delaying or 
cancelling appointments. Women also reported that the inability to find childcare was an 
impediment to screening (Nonzee et al., 2015).  
 Participants in the interviews completed by Marlow et al. (2015) identified full-time jobs 
and the inability to find the time to make an appointment for screening as barriers. Akinlotan et 
al. (2017) found that 13% of survey participants indicated lack of time as a barrier.  
Efforts to Improve 
 The Affordable Care Act (ACA) includes numerous provisions to increase cancer 
screening (Sabik & Adunlin, 2017). The ACA authorizes coverage for cervical cancer 
screenings. Medicare also offers coverage for biannual screening Pap tests and pelvic exams. A 
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woman of childbearing age and at high-risk for cancer with an abnormal Pap test within three 
years would qualify for yearly screening without copayment or deductible if her provider accepts 
Medicare (ACS, 2020a). As previously mentioned, the NBCCEDP provides cervical cancer 
screening to women without health insurance for little to no cost (CDC, 2019b). The Well-
Woman Healthcheck program is a state-wide service that provides eligible women with free 
cervical cancer screening at community health centers and federally qualified health centers. It is 
part of the Bureau of Health Systems Development through the Arizona Department of Health 
Services, with cooperation of the CDC (Arizona Department of Health Services [AZDHS], 
2020). 
 The Title X Family Planning Program assists with the provision of comprehensive family 
planning and preventive health services (Fowler et al., 2017). In 2015, 3.6 million female clients 
obtained care in a Title X-funded facility. Of that, more than 743,000 were screened for cervical 
cancer (Fowler et al., 2017). Although Title X was created to bridge the gap between the insured 
and uninsured receiving care, the percentage of Title X clients screened for cervical cancer 
declined from 51% in 2005 to 21% in 2015 (Fowler et al., 2017).  
Regardless of the political, national and state actions to make insurance and cost 
irrelevant, women are still not screened according to guidelines. Possible remaining barriers are 
anxiety and inadequate funding for programs. These consistent and persistent gaps in screening 
have led to the clinically relevant PICO question: In the underserved female population (P), will 
text and online messaging reminders (I) compared to no reminders (C) affect cervical cancer 
screening rates (O)? 
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Search Strategy 
The databases searched for this literature review included PubMed, CINAHL, and the 
Cochrane Library. Initial search strategy included the keywords: Pap smear, cervical cancer 
screening, reminder, phone call, compliance, and outreach. The Boolean connector “or” was 
used for the main aspects of the PICO question including the intervention and the outcome. 
Intervention was defined as reminder, outreach, or phone call and the outcome of interest 
included Pap smear or cervical cancer screening. To yield a manageable search, limitations of 
humans and female were applied to the keywords. This modified search generated 8,798 
references in PubMed; 1,875 references in CINAHL; and 70 references in the Cochrane Library.  
By setting limits to English language, humans, 18 years of age or older, publication date 
from 2013-1019, and combining terms the results yielded were decreased to a final yield of 874 
references in PubMed; 78 references in CINAHL; and 44 in the Cochrane Library. Ancestry 
searches led to studies published greater than five years ago or studies that had already been 
reviewed and deemed inappropriate for this literature review.  
After critical appraisal of 24 studies, ten have been chosen for inclusion in this literature 
review. Exclusion criteria included unclear documentation, inconclusive evidence, or irrelevant 
to the project aim. Inclusion criteria were that an article evaluated the relationship between 
phone calls and clinic-provided reminders with cervical cancer screenings. 
Critical Appraisal and Synthesis 
 The rapid critical appraisal process described by Melnyk and Fineout-Overholt (2015) 
was used to evaluate the quality of the 10 articles selected for the literature review. Five of the 
studies were found to provide high-level evidence RCTs (Appendix A). Four articles were cohort 
studies, and the remaining study was a quasi-experimental study (Appendix A). All researchers 
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in the selected studies reported their funding source and denied any bias. All 10 studies had large 
sample sizes. The literature review includes an international sampling, with only four studies 
originating in the United States (Appendix A). Six of the interventions were executed in patient 
care clinics, three were based on samples of large databases, and the remaining study was 
executed at a school (Appendix A).  
 Slight heterogeneity was observed in the measurement tools and intervention designs. 
Interventions included letters, phone calls, and texts. One study included an educational 
pamphlet with a reminder call and text, while another study included a motivational interview 
with a reminder call (Appendix A; Appendix B). The researchers assessed completion of the Pap 
smear or intention to treat as a dependent variable.  
 In eight of the studies, researchers reported a significant increase or a moderate level of 
evidence suggesting an increase in Pap smear completions or intention to treat following the 
interventions. All intervention types had a positive effect on outcomes. The remaining two 
studies had an inconclusive effect (Appendix B). Strong reliability and validity can be assumed 
for all the selected studies due to high-quality measurement tools, rigorous methodology, and 
prevalence of statistically significant results (Appendix A).  
Conclusion 
 Cervical cancer remains a life-threatening disease for women. The Pap test is an effective 
screening method to detect cancer cells early enough for treatment. Although mortality rates 
have decreased since the implementation of the pap test, screening rates remain lower than the 
Healthy People 2020 goal (ODPHP, 2020). National funding is in place to ensure women receive 
this life-saving screen at little to no cost. Clinics must find a way to encourage their patients to 
be screened. This literature review demonstrates the range of interventions being explored to 
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address low cervical cancer screen rates. While there are different approaches to increase Pap 
smear completion, current evidence suggests that phone call or text reminders are effective 
interventions to motivate women to receive screening (Appendix A; Appendix B). There is 
evidence in the studies included in this review that letters and educational pamphlets may 
motivate, empower, and encourage women to make an appointment for this potentially life-
saving test (Appendix B).  
Conceptual Framework and Quality Improvement Model 
 The Interactive Model of Client Health Behavior (IMCHB), developed by Cheryl Cox, is 
intended to address individual behavior through the uniqueness of the client (termed the client 
singularity element) and the influence of the healthcare provider through the client-provider 
element (Mathews, Secrest, & Muirhead, 2008). The purpose of the IMCHB is to identify the 
relationship between client singularity, client-provider relationship and ensuing client health care 
behavior (Mathews et al., 2008). A visual representation of the model demonstrates the variables 
that influence each element (Appendix C).  
 The IMCHB suggests that providers should first assess client background variables such 
as access to healthcare, demographics, and previous experience with health care (Mathews et al., 
2008). These variables affect client motivation and cognitive perception of health. The client-
professional interaction has a major influence on healthcare behavior, involving four 
components: health information, affective support, decisional control, and professional 
competencies (Mathews et al., 2008).   
 The ACE Star Model of Knowledge Transformation (Appendix D) offers a simple yet 
comprehensive approach to translate evidence into practice (Stevens, 2012). The Star Model 
emphasizes crucial steps to convert one form of knowledge to the next and incorporates best 
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research evidence with clinical expertise and patient preferences (Stevens, 2012). Represented as 
a five-point star, the model defines various forms of processing evidence: discovery, summary, 
translation, integration, and evaluation (Stevens, 2012). The goal of knowledge transformation is 
quality improvement of healthcare processes and outcomes.  
 When applied to cervical cancer screenings, providers should assess the variables that 
may affect the client’s ability to receive care, and their beliefs associated with receiving a Pap 
smear. With this information, the provider can evaluate patient hesitancy or barriers to screening, 
select and implement a tested intervention, and assess the outcome for further practice. 
Implications for Practice Change 
 Cervical cancer is a preventable and treatable disease that remains a threat to female 
health and mortality. The Pap smear is recommended as part of routine gynecological screening 
to detect abnormal cells early and intervene appropriately before they become a malignancy. The 
impacts of cervical cancer are numerous; therefore, key stakeholders in proactive cervical cancer 
screening include: The female population in the United States, healthcare providers, insurance 
companies, government officials, and the public that ultimately bears the cost of cervical cancer 
treatment and the emotional impact when loved ones are involved.  
 Heterogeneity in program design implies that different kinds of interventions can 
effectively increase cervical cancer screening rates. Though heterogeneity is seen in the 
evidence, patient reminders involving phone calls, texts, and education have proven to be most 
effective (Appendix F). Healthcare systems across the United States should design and 
implement feasible reminder systems that will empower the patient to obtain routine, potentially 
life-saving screenings.  
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Patients should have access to culturally and linguistically appropriate educational 
material in the clinic to provide information on the importance and value of screening. Clinics 
should complete phone calls and text reminders that include accommodations for the visually 
and hearing impaired before USPSTF recommended patient screening is due. Recording pap 
smear completion percentages is recommended to monitor outcomes of the reminder strategy. 
Following the intervention, details outlining the program design and results should be published 
to guide further practice.  
Methods 
Inclusion and Exclusion Criteria 
  Inclusion criteria were female patients aged 21 to 65 years who have had an office visit in 
the past 2 years but have not had a pap test in the past 3 years. Patients involved are English and 
Spanish speaking and registered onto the messaging system. 
Exclusion criteria were patients who have opted out of being contacted via electronic 
messages, patients who have not been to the clinic in over 2 years, patients with a history of 
hysterectomy, and female patients who had a pap test within 3 years. Minors and women under 
age 21 were excluded because the standard of care is to initiate cervical cytology screening until 
age 21. Pregnant women not included because a pap test is routinely performed as part of 
prenatal care. Women who were prisoners, Native Americans, and undocumented were not 
specifically included or excluded. 
Ethical Considerations 
  The Arizona State University Institutional Review Board approved this project as 
exempt. Patients specify how they prefer to be contacted when they register to the clinic. De-
identified data was obtained using the clinic EHR. Data was stored on a password protected 
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server at the project site. Because the collected data will be part of the routine reporting of 
uniform data system (UDS) required by federal agencies, the data will be stored for up to 7 years 
under the usual processes for the maintaining the security of patient health information (PHI).  
Those who had access to the data include Maria Babb (project director), the primary investigator 
and faculty mentor, Dr. Denise Link, the Arizona State University Graduate Research Support 
Department, the patient advocate at Wesley Community Health Center, Gabby Hernandez, the 
quality improvement registered nurse, Lisa Carranza, and the project champion at Wesley, Dr. 
Caitlin Lee. Other clinic personnel concerned with cervical cancer screening had access to the 
de-identified data. No personal identifiers will be collected or stored with the data. 
Project Description 
Patients from Wesley Health Center specify when first registered to the clinic the method 
of communication by which they would like to be contacted, if any. The staff sent out a 
motivational message with educational resources to patients via text message or health portal 
message, depending on the patients’ stated preferred method of contact. Materials used to remind 
patients were notice of overdue screening (per USPSTF guidelines), a motivational message, and 
educational material regarding cervical cancer screening. The educational material was provided 
by the National Cancer Institute (2019), and the reminder message was uploaded from the EHR.  
The message was sent instantly through the EHR. Patients that met the eligibility criteria 
to receive the messages were identified by the EHR through a pre-set process that selects the 
appropriate patients. The reminder utilized mass motivational messaging to enhance the strength 
of patients’ attitudes toward potentially avoiding cancer, prompting them to stay up to date on 
screening, and improve overall screening rates at the clinic. 
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The number of patient appointments made following the reminder text were collected two 
months after the message is sent. The staff will query the EHR to determine the number of 
patients that successfully received the message, the number of patients that made an appointment 
for a pap smear after receiving the message, and then number of patients that did not respond 
and/or did not successfully receive the message. The data was assessed using established 
Uniform Data System for coding visits that include a pap test among women who met the criteria 
for receiving the message. No patient records were queried to determine if specific individuals 
scheduled or completed appointments for a pap test.  
Age, ethnicity, and insurance status of patients who made an appointment following the 
reminder were collected and reported in aggregate to assess and compare the response to the 
intervention based on the three identified demographic characteristics. No individual patient 
records were accessed. There was no long term follow up. There was no compensation for 
patients who obtain a pap test during the project period.  
There were no costs to patients other than what they would otherwise incur as a result of 
obtaining a pap test during the project. The cost of the reminder system through E-Cerner Works 
(ECW) cost $0.15 per patient, or $216 total. Costs of the project were offset through Title X and 
Well Woman HealthCheck Program funding (Appendix E). 
Results 
In total, 1,710 patients successfully received the message, 156 responses were collected, 
and 28 patients made an appointment for screening. This represents a 2% improvement from 
previous months. Summary statistics were calculated for each interval and ratio variable. 
Frequencies and percentages were calculated for each nominal variable. 
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Frequencies and Percentages 
The most frequently observed category of Ethnicity was Hispanic/Latina (n = 24, 86%). 
The most frequently observed category of Insurance was Title X (n = 13, 46%). The average age 
of patients included in the data report was 41.04 with a range of 21 years to 58 years of age (SD 
= 9.93). The summary statistics can be found in Appendix F.  
Discussion 
Unlike the studies in the literature review, this project was completed at a FQHC where 
patients are mostly uninsured, underinsured, and may not have ever received a Pap test before. 
The project brought awareness to patients about the importance of screening and the availability 
of government assistance programs to help them receive screening at little to no cost. The project 
also helped expedite reminders to patients, saving staff time and resources. Although the number 
of appointments made in response to the message were small, the number of patients responding 
to the message was significant, suggesting the potential to have a greater impact if changes are 
made to the intervention. The project can be sustained if patient overdue screening statuses were 
updated in the EHR and the patient response to the reminder message were more interactive. 
Limitations and Barriers 
 Patients at Wesley do not exclusively obtain their recommended cervical cancer 
screenings at that site. Many patients seek care at other Maricopa County clinics, and staff at 
Wesley are often left with the task of requesting outside records. An interactive type of message 
may be more useful and enable Wesley to document that the women are being appropriately 
screened and improve the accuracy of their compliance with pap testing standards.  
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 The message was unclear. Patients were given the option to reply ‘yes’ or ‘no’ if they 
were up to date on testing. Upon data analysis, it appeared many patients were responding ‘yes’ 
to needing an appointment when they were responding that they were already up to date.  
Recommendations for Future Research 
 The EHR reminder system allowed for the message to be revised. Instead of stating if 
they recently had testing, the patients should have simply been able to choose to make an 
appointment or not in response to the message to better determine the effectiveness of the 
message. A smaller sample size of active patients with known overdue Pap test status may have 
helped determine if the message prompted patients to make an appointment. After patients 
confirm an appointment date, reminders should be sent to ensure the patient arrives for their 
appointment. 
Conclusion 
 Cervical cancer remains a leading cause of gynecological death for women in the United 
States despite the availability and effectiveness of preventive screening. Populations most 
affected are minority and underserved women. Barriers to screening include anxiety, lack of 
awareness, and fear of out of pocket costs. A motivational message sent to patients at a FQHC 
with a notice of overdue screening, patient education regarding cervical cancer, and information 
about government assistance for free or low cost screening resulted in a 2% increase in 
screening. Further research is necessary to observe methods to improve cervical cancer screening 
among vulnerable, underserved women. 
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effectiveness 
of a 
telephone 
call offering 
an 
appointment 
for a Pap 
smear or by 
mail 
offering a 
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CG: Mail 
reminder 
 
IV: telephone 
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None 
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Promotion 
Model 
Design: 
Prospective 
Cohort Study 
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To compare 
response 
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Pap/HPV  
co-test 
completion) 
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women sent 
electronic or 
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N=773 
IV:  
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CG: 
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Demographi
cs: 
M age: 
43.9yrs 
A: 2.5% 
AA: 7.0% 
C: 89.3% 
L: 1.2% 
 
Setting: 
Three 
primary care 
sites 
associated 
with Mayo 
Clinic in 
Rochester, 
Minnesota 
CG: Mailed 
letter 
 
IV: 
Electronic 
reminder 
 
DV: 
Completion 
of Pap or 
Pap/HPV  
co-test 
 
CDSS  
 
Response rates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
mean (SD), 
count, 
percentages 
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estimating 
equation 
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Logistic 
regression 
model 
DV:  
IV: 
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CG: 
3.3%, OR 
8.27, 
95% CI 
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significan
t 
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Developed CDSS to 
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Limitation: 
Primarily white and 
insured patients, 
distinctiveness of 
CDSS limit to only 
Mayo practice 
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Conclusion: 
Significant increase 
in test completion; 
CDSS enables 
delivery of 
individualizing care 
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Feasibility: CDSS 
may not be feasible in 
CERVICAL CANCER                                                                                      29 
 
Key:  AA- African American; ACS- American Cancer Society; A- Asian; C- Caucasian; CC- Cervical Cancer; CDSS- Clinical Decision Support 
System; CG–Control Group; CI- Confidence Interval- DV-dependent variable; E- Employed; G- Gender; HIV-Human Immunodeficiency Virus; 
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Assistant; RCT-Randomized Controlled Trial; RL-Registered Letter; RR- Risk Reduction; S-Student; SD-Standard Deviation; SIPPS- Pap smear 
program information system; SMS- Short Message System; U-Unemployed; UTD- Up to Date; Wks-Weeks; Yrs- years 
 
 
Inclusion: 
Women 18-
65 yrs at high 
risk for CC 
 
High Risk:  
Women with 
hx abnormal 
pap test, 
HPV test, or 
colposcopy 
overdue for 
follow-up, 
and women 
with previous 
cancer, HIV, 
or other 
immunodefic
iency with 
>1yr since 
pap 
 
Exclusion: 
Women with 
appointment, 
low life-
expectancy, 
 
 
 
 
 
all practices, but 
electronic and written 
reminders were 
shown to be effective  
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Assistant; RCT-Randomized Controlled Trial; RL-Registered Letter; RR- Risk Reduction; S-Student; SD-Standard Deviation; SIPPS- Pap smear 
program information system; SMS- Short Message System; U-Unemployed; UTD- Up to Date; Wks-Weeks; Yrs- years 
 
Previous care 
at outside 
facility 
 
Attrition: 
N/A 
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Conceptual 
Framework 
Design/ 
Method 
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Major 
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& 
Definitions 
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on 
Data 
Analysis 
Findings
/ 
Results 
Level of Evidence/ 
Application to 
Practice 
Abdul Rashid et 
al. (2013). Is the 
phone call the 
most effective 
method for recall 
in cervical 
cancer 
screening? 
Results from a 
randomized 
control trial. 
 
Country:  
Malaysia 
 
Funding: 
Health 
Promotion 
Model 
Design: 
Prospective, 
randomized 
control study 
 
Purpose: 
To compare 
the 
effectiveness 
of different 
methods of 
recall for 
repeat Pap 
smear among 
women who 
had normal 
N=1,000 
 
CG:250 
IG1:250 
IG2:250 
IG3:250 
 
Demographi
cs: 
M age group: 
35-44.9yrs 
Malaysian: 
72% 
Chinese: 
13% 
Indian: 15% 
CG:Letters 
IV2:RL 
IV3:SMS 
IV4: Call 
 
DV1: Pap 
smear 
completion 
DV2: No 
pap smear 
OpenEpi 
Program, 
SIPPS, 
percentages 
SPSS, X2 
test, binary 
logistic 
regression 
DV1: 
CG: 
18.8% 
IV1: 
20.0%, 
IV2:21.6
% 
IV3:34.4
% 
 
DV2: 
CG: 
81.2% 
IV1: 
80.0%, 
p>0.05, 
LOE: II 
 
Strength: RA 
blinded to 
intervention; RCT  
 
Weaknesses: 
selection bias, only 
phone call yielded 
significant results, 
p>0.05 for SMS and 
registered letter, 
outreach only to 
women previously 
tested and more 
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Assistant; RCT-Randomized Controlled Trial; RL-Registered Letter; RR- Risk Reduction; S-Student; SD-Standard Deviation; SIPPS- Pap smear 
program information system; SMS- Short Message System; U-Unemployed; UTD- Up to Date; Wks-Weeks; Yrs- years 
 
University of 
Malaysia, Kuala 
Lumpur 
Bias: selection 
bias: only chose 
women who had 
previous normal 
pap smear 
smears in the 
previous 
screening. 
 
Setting: All 
community 
clinics in 
Klang under 
the MHMM 
 
 
Inclusion: 
Responded to 
first email, 
no diagnosis 
of positive 
smear, due 
for next 
screening 
 
Exclusion: 
Abnormal 
first pap 
smear 
Attrition: 
19% 
OR 1.13, 
CI 0.72-
1.77. 
IV2: 
78.4%, 
p>0.05, 
OR 1.20, 
CI 0.76-
1.87 
IV3: 
65.6%, 
p<0.05, 
OR 2.38, 
CI 1.56-
3.62  
likely to come back 
on own 
 
Conclusion: 
Significant positive 
feedback from phone 
call group 
 
Feasibility: Phone 
call reminders can be 
done in office 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables/ 
Definitions 
Measurement/
Instrumentati
on 
Data  
Analaysis 
Findings
/ 
Results 
Level of Evidence/ 
Application to 
Practice 
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Ganta et al. 
(2017). Timely 
reminder 
interventions to 
improve annual 
Papanicolaou 
(pap) smear rates 
among HIV-
infected women 
in an outpatient 
center of 
southern 
Nevada: A short 
report 
 
Country: United 
States 
 
Funding: HRSA 
Ryan White Part 
D Program and 
Healthy Sunrise 
Program 
 
Bias: None 
Health 
Promotion 
Model 
Quasi-
experimental 
 
Purpose: To 
test the 
effectiveness 
of reminders 
by phone call 
or text on 
improvement 
of pap smear 
rates 
N= 485 
 
Demographi
cs:  
M age: 46.7 
years 
AA 54.6% 
 
Setting: HIV 
wellness 
center in 
southern 
Nevada 
 
Inclusion: 
No pap 
smear in past 
year, 18 yrs 
and older, 
HIV positive 
 
Exclusion: 
hysterectomy
, already 
diagnosed 
cervical 
carcinoma, 
male-to-
CG: before 
communicat
ion effort 
 
IV: Texts 
and phone 
calls 
 
DV: pap 
smear 
completion 
ACCESS 
database, 
percentages, 
response rates 
McNemar’s 
test for 
marginal 
homogeneit
y. SAS 
version 9.2 
DV: 
CG: 
2.5% 
IV: 
11.8%, 
p<0.0001 
 
LOE: III 
 
Strength:  
Significant increase 
in pap smear 
completion with 
intervention 
 
 
Weakness: 
Participants given 
$10 gift card, did not 
specify if participants 
knew in advance; 
could have altered 
success of study 
 
Feasibility: 
Intervention can be 
done in office.  
Most patients respond 
to communication via 
phone 
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female 
transgender, 
moved out of 
country 
Attrition: 
4% 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables/ 
Definitions 
Measurement/ 
Instrumentati
on 
Data 
Analysis 
Findings
/ 
Results 
Level of Evidence/ 
Application 
to 
Practice 
Firmino-
Machado et al. 
(2017). Stepwise 
strategy to 
improve cervical 
cancer screening 
adherence 
(SCANN-CC): 
Automated text 
messages, phone 
calls and face-to-
face interviews: 
Protocol of a 
population based 
randomized 
controlled trial. 
Health 
Promotion 
Model 
RCT 
 
Purpose: To 
test the 
effectiveness 
of invite to 
cervical 
cancer screen 
through low-
cost, 
customized 
text messages, 
phone calls 
and reminders. 
N=1220 
CG: 615 
IV: 605 
 
Demographi
cs: 
M age group: 
25-34 yrs 
S: 4.6% 
E: 71.9% 
U: 22.1% 
R: 1.5% 
 
Setting: 13 
Portuguese 
primary care 
units 
CG: 
Invitation 
by letter 
 
IV: Phone 
call/text 
message 
 
DV: ITT 
1:1 
Randomization 
sequence, 
percentages, 
ITT 
Chi-squared 
tests, binary 
logistic 
regression, 
stratified 
analysis. 
DV: 
CG: 
25.7% 
IV: 
39.0%, 
OR 1.85 
(95% CI 
1.45-
2.36) 
LOE: II 
 
Strength: 
population-based 
RCT 
 
Weakness: only 
included women 
under 50 years old, 
non-blinded study,  
 
Feasibility: Can be 
done in office. Cost-
effective.  
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Country: 
Portugal 
 
Funding:  ACeS 
Porto Ocidental 
and Marão e 
Douro Norte 
and the Instituto 
de Saúde Pública 
da Universidade 
do Porto(ISPUP). 
 
Bias: none 
 
Inclusion: 
Age 25-49yrs 
Female, 
Eligible for 
screening, 
member of 
primary care 
units that 
preform 
letter 
invitations  
 
Exclusion: 
no mobile 
phone 
number on 
national 
database 
 
Attrition: 
none 
Citation Theoretical/
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables/
Definitions 
Measurement/ 
Instrumentati
on 
Data/ 
Analysis 
Findings
/ 
Results 
Level of  
Evidence/ 
Application to 
Practice 
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MacLaughlin et 
al. (2014).  
Cervical cancer 
screening: A 
prospective 
cohort study of 
the effects of 
historical patient 
compliance and 
population-based 
informatics 
prompted 
reminder on 
screening rates. 
 
Country: 
United States 
 
Funding: 
Mayo Clinic 
 
Bias: 
None noted 
Health 
Promotion, 
Transtheoreti
cal Model 
Prospective 
cohort study 
 
Purpose: 
To assess the 
impact of 
historical 
screening 
compliance 
with the 
effectiveness 
of patient 
reminder 
letters on 
cervical 
cancer 
screening 
rates. 
N=2,701 
 
CG:total 
1,906 
NE UTD: 
507 
NW UTD: 
360 
NE OD: 
1,106 
NW OD: 
728 
 
IV: 795 
 
Demographi
cs: 
M age group: 
35-39yrs 
C: 86.8% 
 
 
Setting: 
MFC NE and 
MFC NW 
 
Definition: 
UTD: 
CG: No 
letter 
 
IV: Patient 
reminder 
letters 
 
DV: ITT 
Percentages of 
ITT 
γ2 
test (Fisher’s 
exact test for 
rare 
characteristic
s), 
Bonferonni 
correction, 
MLR, SAS 
9.2,  
DV:  
CG:  
NE UTD: 
80.3%, 
(p<0.001
) 
NW 
UTD: 
75.1% (p 
0.007) 
NE OD: 
39.3% 
(p<0.001
) 
NW OD: 
38.9% 
(p<0.001
) 
 
IV: 
39.0%, 
(p<0.001
) 
 
 
LOE: IV 
 
Strength: Produced 
statistically 
significant results 
 
Weakness:  More 
positive feedback 
from already-
compliant group. Not 
significant ITT in OD 
groups.  
 
Feasibility: 
Can be done in office 
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Last pap 3 
years ago 
OD: 
Unknown 
last pap date 
 
Inclusion: 
Women 21-
64yrs, no 
cervical 
cancer 
screening 
within 3 yrs 
of study 
 
Exclusion:  
Hx CC or 
hyst 
 
Attrition: 
22.6% 
Citation Theoretical/
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Design/ 
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Setting 
Major 
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Bowles et al. 
(2016). 
Comparative 
effectiveness of 
two outreach 
strategies for 
cervical cancer 
screening 
 
Country: 
United States 
 
Funding: 
ACS, NCI 
 
Bias: none 
Health 
Promotion, 
Transtheoreti
cal Method 
Design: 
Cohort study 
Purpose: 
To compare 
the 
effectiveness 
of a birthday 
reminder 
letter to a 
cervical 
cancer 
screening-
specific 
reminder 
letter on Pap 
test 
adherence 
N=119,497 
 
IV1: 53,571  
 
IV2: 65,926 
  
Demographi
cs: 
M age group: 
51-65 yrs 
C: 58.7% 
Not C: 
14.9% 
Unknown: 
26.4% 
 
Setting: 
Group 
Health, 
healthcare 
delivery 
system in 
Washington 
State 
 
Inclusion: 
21-64 yrs, 
IV1: Pap 
letters 
 
IV2: 
Reminder 
Birthday 
Letters 
 
DV: 
Adherence 
to CC 
screen 
 
 
Percentages of 
pap completion 
95% CI to 
unadjusted 
adherence to 
CC screen, 
SAS 
DV: 
IV1 
UTD: 
46.8%, 
95% CI 
(46.3, 
47.4) 
IV1 OD: 
22.1% 
95% CI 
(21.7, 
22.5) 
 
IV2 
UTD: 
26.0%, 
95% CI 
(25.7, 
26.3) 
IV2 OD: 
21.6%, 
95% CI 
(21.2, 
22.1), 
p<0.001 
LOE:  IV 
 
Strength: Can be 
done in office, cost-
effective 
 
 
Weakness:  Lack of 
control group, UTD 
patients had highest 
adherence (unknown 
if intervention was 
the factor) 
 
Feasibility: Provides 
insight which 
reminder 
interventions work 
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Continuously 
enrolled in 
GH for 3 yrs 
before study. 
 
Exclusion: 
Hysterectom
y, multiple 
letters 
received, not 
enough time 
between 
letter and pap 
due date 
 
Attrition: 
59.4% 
 
Citation 
 
Theoretical/
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables/ 
Definition 
Measurement/ 
Instrumentati
on 
Data/ 
Analysis 
Results/ 
Findings 
Level of Evidence/ 
Application to 
Practice 
Tavasoli et al. 
(2016). Impact 
of invitation and 
reminder letters 
on cervical 
Transtheoreti
cal Model; 
Health 
Promotion  
Cohort study 
 
Purpose: 
Explore the 
impact of 
N: 229, 459 
 
CG: 130,181 
IV: 99,278 
 
IV: 
Invitation to 
screen letter 
 
Percentages of 
ITT 
Cross-
sectional 
analysis, 
Univariate 
analysis, chi-
DV: 
CG: 
8.5% 
IV: 
14.1%, 
LOE: IV 
 
Strengths: 
significant result, had 
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cancer screening 
participation 
rates in an 
organized 
screening 
program 
 
Country: 
Canada 
 
Funding: 
Cancer Care 
Ontario;  
Bias: none 
invitation 
and reminder 
letters on Pap 
uptake 
comparing 
women who 
received the 
intervention 
with a 
historical no-
intervention 
group 
Demographi
cs: 
M age group: 
50-54yrs 
No pap 
>5yrs: 76.9% 
Pap 3-5yrs: 
23.1% 
Urban 
Lowest 
income: 
19.2% 
Urban 
highest 
income: 
15.8% 
Rural Lowest 
income: 
0.01% 
Rural highest 
income: 
0.02% 
 
Setting: 
Ontario 
 
Inclusion: 
DV: Pap 
completion/
ITT within 
9 months 
 
 
square test, 
sensitivity 
analysis, 
bivariate 
analysis 
(OR=1.8, 
95% CI 
1.7-1.8) 
a control group, large 
sample size 
 
Weakness: could not 
randomize, unknown 
how many women 
did not receive letter, 
only returned letters 
were considered not 
received 
 
Application to 
Practice: 
Can be done in 
office, cost-effective 
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Women 30-
69yrs. No 
pap in 3 yrs.  
No colpo for 
dysplasia in 
3 yrs. 
 
Exclusion: 
Hysterectom
y, recent pap 
 
Attrition: 
13.7% 
 
Citation Theoretical/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major  
Variables/ 
Definition 
Measurement/ 
Instrumentati
on 
Data/ 
Analysis 
Results/ 
Findings 
Level of  
Evidence/ 
Application to 
Practice 
Abdullah, F., & 
Su, T.T. (2013). 
Applying the 
transtheoretical 
model to 
evaluate the 
effect of a call-
recall program in 
enhancing pap 
Transtheoreti
cal Model 
Two-armed, 
paralleled 
group, 
unblinded 
cluster 
randomized 
trial 
 
Purpose: 
N= 398 
 
CG: 202 
IV: 201 
 
Demographi
cs: 
M age: 
IV 36.1 ± 8.0 
IV: personal 
invitation 
letter with 
information 
pamphlet, 
followed by 
telephone 
reminder 
 
Percentages of 
action stage 
t-test for 
continuous 
variables, chi 
square test 
for 
categorical 
data. 
Multivariate 
logistic 
HL 
GOTT: 
3.74 
(p=0.880
) 
indicates 
well 
calibrated 
model 
LOE: II 
 
Strength: RCT, 
produced significant 
results 
 
Weakness: 
unblinded, 
participants knew 
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smear practice: 
A cluster 
randomized trial 
 
Country: 
Malaysia 
 
Funding: 
University of 
Malaysia 
 
Bias: 
none 
To evaluate 
the effect of 
a call-recall 
approach in 
enhancing 
pap smear 
practice by 
changes of 
motivation 
stage among 
non-
compliant 
women 
CG 36.5 
±7.3, p 
=0.455 
 
Education 
IV:  
Graduate 
Degree 90.0 
CG: 
Graduate 
Degree 89.1, 
p=0.939 
 
Previous pap 
IV: 34.3 
CG: 41.6 
P=0.133 
 
Setting: 
Public 
secondary 
schools 
 
Inclusion:  
Female 
secondary 
teachers 
naïve to pap 
CG: usual 
care/no 
intervention 
 
DV: pap 
smear 
completion 
within 24 
wks 
regression, 
univariate 
analysis, HL 
GOTT, 
SPSSv15 
DV: 
IV: 
18.1% 
Univariat
e 
modeling 
OR 1.98, 
95% CI 
1.1-3.5 
Multivari
ate 
modeling 
OR 2.44, 
95% CI 
1.29-
4.62, p≤ 
0.25 
 
CG:10.1
% 
 
they were being 
studies which could 
have affected 
outcome 
 
Application to 
Practice: 
Can be done in  
office, Shows promise 
in reaching normally 
hard-to-reach patients 
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smear or had 
their last test 
>3 yrs  
Exclusion: 
no response 
 
Attrition: 
0.2% 
Citation Theoretical/
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major  
Variables/ 
Definition 
Measurement/ 
Instrumentati
on 
Data/ 
Analysis 
Results/ 
Findings 
Level of  
Evidence/ 
Application to 
Practice 
Nicolau et al. 
(2017).  
Telephone 
interventions in 
adherence to 
receiving the pap 
test report: A 
randomized 
clinical trial. 
 
Country:  
Brazil 
Funding: 
None specified 
 
Transtheoreti
cal Model/ 
Health 
Promotion 
Model 
RCT 
 
Purpose: 
To test the 
efficacy of 
the 
behavioral 
and 
educational 
interventions 
using the 
telephone for 
women’s 
attendance at 
the 
N=510 
CG: 169 
IV1: 171 
IV2: 170 
 
M age: 
CG: 36.4yrs 
IV1: 37.4yrs 
IV2: 37.9yrs 
 
Marital 
Status: 
CG: 
With partner:  
52% 
IV1: 
telephone 
call/educati
onal 
intervention 
(motivation
al interview) 
 
IV2:  
Telephone 
call/reminde
r 
intervention 
 
Frequencies 
and 
percentages 
SPSS v20.0, 
mean, SD, CI 
95%, 
frequencies 
and 
percentages, 
ANOVA, 
Pearson Chi-
Squared Test 
DV: 
CG: 
66.9%,  
IV1: 
91.8%, 
p=0.000, 
RR 1.39 
CI 95% 
(1.24-
1.55) 
 
IV2: 
93.5%, 
p=0.000, 
RR 1.40, 
LOE: II 
 
Strength: blinded 
RCT, significant 
results; simple and 
efficacious 
interventions 
 
Weakness: 
Short time period for 
assessing return 
 
Application to 
Practice: 
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program information system; SMS- Short Message System; U-Unemployed; UTD- Up to Date; Wks-Weeks; Yrs- years 
 
Bias:  
None specified 
consultation 
where they 
receive the 
pap test 
report 
No partner: 
48% 
IV1: 
Partner: 
50.3% 
No Partner: 
49.7% 
IV2: 
Partner: 
55.8% 
No Partner: 
44.2% 
 
Setting: 
Ligia Barros 
Costa 
Natural Birth 
Center, 
Brazil 
 
Inclusion: 
>18yrs, 
Initiated 
sexual 
activities, to 
undertake 
pap test in 
data 
CG: 
comparison 
group 
 
DV: Patient 
return rate 
CI 95% 
(1.25-
1.57 
 
 
Simple, low-cost, and 
fast intervention that 
can be done in office 
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Key:  AA- African American; ACS- American Cancer Society; A- Asian; C- Caucasian; CC- Cervical Cancer; CDSS- Clinical Decision Support 
System; CG–Control Group; CI- Confidence Interval- DV-dependent variable; E- Employed; G- Gender; HIV-Human Immunodeficiency Virus; 
HL GOTT-Hosmer-Lemeshow Goodness-of-Fit Test; HPV-Human Papilloma Virus; Hyst- Hysterectomy; Hx-History; IG- Intervention Group; 
ITT-Intention to Treat; IV- independent variable; L- Latina; LOE- Level of Evidence; M-Mean; MFC- Mayo Family Clinic; MHM- Ministry of 
Health Malaysia; MLR-Multivariate Logistic Regression; N-number of studies; n- number of participants; NCI- National Cancer Institute; NE-
Northeast; NPR- National Population Register; NW- Northwest; OD-Overdue; OR-Odds Ratio; Pap- Pap smear; R-Retired; RA- Research 
Assistant; RCT-Randomized Controlled Trial; RL-Registered Letter; RR- Risk Reduction; S-Student; SD-Standard Deviation; SIPPS- Pap smear 
program information system; SMS- Short Message System; U-Unemployed; UTD- Up to Date; Wks-Weeks; Yrs- years 
 
 
collection 
period, and 
have mobile 
or telephone 
 
Exclusion: 
Pathology 
related to 
mental 
processes, 
speaking, or 
hearing, 
which would 
make it 
difficult to 
respond to 
questionnaire  
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Key: LOE- Level of Evidence; ER- Electronic Reminder; SMS- text; L/P/T- Letter/Pamphlet/Telephone; 
MI- Motivational Interview; BL- Birthday Letter 
Appendix B 
Synthesis Table 
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Year 2013 2018 2013 2017 2017 2014 2016 2016 2013 2017 
LOE II IV II III II IV IV IV II II 
Design RCT PCS PRCT QE RCT PCS CS CS TAPG, 
UCRT 
RCT 
Number of 
Participants 
8,800 773 1,000 485 1,220 2,701 119,497 229,459 398 510 
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 X X X 
Small pap 
smear 
increase 
     X X    
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increase 
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Appendix C 
Interaction Model of Client Health Behavior 
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Appendix D 
ACE Star Model of Knowledge Transformation 
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Appendix E 
Budget Plan 
Budget 
 
Phase Activities Cost subtotal Total 
Direct Costs Specimen collection devices for 
pap smear (Sonora Quest lab) 
$0   
Gloves ($2.95/100 gloves) $84.96   
Plastic disposable speculum 
($5.00/10) 
$720   
Blue Chux  ($24.59/pack of 50) $708.19   
Wipes ($6.28/240 pack) $37.68   
Reminder system use through 
EClinical Works($0.15/patient) 
$216   
EHR Build $96   
Reminder system use   $160 $2,022.83  
Indirect Costs EMR reminder system training: 
Medical Assistant 
$240   
Translator training $160   
Front desk staff training $240 $640  
Funding Title X   Offsets 
costs 
$0 
 Well Woman Health Check 
Program (WWHCP) 
 Offsets 
costs 
$0 
Potential 
Revenue 
Title X ($124.78/patient) $17,968.32   
 WWHCP ($73.81/patient) $95,657.76  $113.626.08 
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Budget Justification:     The project is creating a mass reminder system through the 
EHR, EClinical Works, to encourage patients who are overdue for cervical cancer 
screenings to make an appointment for updated screening. 
The budget is based on the 1,440 patients who are overdue. The staff involved are the 
ones carrying out the intervention (IT support, medical assistants, front desk staff, and 
translators). 
 
A. Direct Costs 
a. Materials used to collect cervical cancer screening specimen.  
b. Reminder system is using the EMR portal to send reminder messages to 
patients to make an appointment for screening. The system charges $0.15 per 
patient when sending a mass message 
c. EHR build based on $24/hr average pay for IT support. Estimate 4 hours for 
EHR build. 
d. Reminder system use: Assuming it will take 1 hour to send mass reminder 
message per MA, front desk staff, and translator.  
B. Indirect costs 
a. Average medical assistant and front desk staff pay $15/hr. Estimate 4hrs to 
complete training for new EHR reminder system. Cost is based on 4 employed 
medical assistants and 4 front desk staff 
b. Average translator pay $20/hr. Estimate 4hrs to complete EHR training. Cost 
based on 2 employed translators. 
C. Funding 
a. Provided by Title X and WWHCP. The amount given to the clinic will cover 
the costs of the project. 
D. Potential Revenue 
a. Title X allots $218,375 for 1,750 patients. This comes out to $124.79 per 
patient. (124.79 x 1,440 = 179,691) 
b. WWHCP reimburses $73.81 for each well woman exam.  
c. If the reminder system is successful and all overdue patients come in for their 
cervical cancer screening, the clinic would receive extra reimbursement 
money  
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Appendix F 
Descriptive Statistics 
Frequency Table for Nominal Variables 
Variable n % 
Ethnicity     
    Hispanic/Latina 24 85.71 
    Declined to Specify 4 14.29 
    Missing 0 0 
Insurance     
    Insured 2 7.14 
    Well Woman Health Check 8 28.57 
    Title X 13 46.43 
    Insured; Title X 1 3.57 
    Title X; Insured 1 3.57 
    Sliding Fee 2 7.14 
    Title X; Well Woman Health Check 1 3.57 
    Missing 0 0 
Note. Due to rounding errors, percentages may not equal 100%. 
 
Summary Statistics Table for Interval and Ratio Variables 
Variable M SD n  Min Max   
Age 41.04 9.93 28  21.00 58.00   
Note. '-' denotes the sample size is too small to calculate statistic. 
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Pie Chart of Insurance 
Pie Chart of Ethnicity
 
